Occidental Asset Management LLC Makes New Investment in Hims & Hers Health, Inc. $HIMS

Key Points

• Occidental Asset Management LLC has made a new investment in Hims & Hers Health, purchasing 6,112 shares worth approximately $305,000 in the second quarter.
• Insider selling has occurred recently, with CEO Andrew Dudum selling 660,000 shares for about $33 million, and CFO Oluyemi Okupe selling 145,000 shares valued at about $8 million.
• Hims & Hers Health reported a quarterly EPS of $0.17, missing estimates, and experienced a significant year-over-year revenue growth of 72.6%, despite falling short of revenue expectations.

Occidental Asset Management LLC purchased a new position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 6,112 shares of the company's stock, valued at approximately $305,000.

Other hedge funds also recently modified their holdings of the company. Signaturefd LLC grew its position in shares of Hims & Hers Health by 17.7% in the 1st quarter. Signaturefd LLC now owns 2,586 shares of the company's stock valued at $76,000 after purchasing an additional 388 shares during the period. Lake Hills Wealth Management LLC acquired a new position in shares of Hims & Hers Health in the second quarter valued at approximately $277,000. Fiduciary Alliance LLC boosted its holdings in shares of Hims & Hers Health by 120.4% in the second quarter. Fiduciary Alliance LLC now owns 109,253 shares of the company's stock valued at $5,446,000 after buying an additional 59,686 shares during the period. GAMMA Investing LLC increased its position in shares of Hims & Hers Health by 128.5% during the first quarter. GAMMA Investing LLC now owns 5,143 shares of the company's stock worth $152,000 after acquiring an additional 2,892 shares in the last quarter. Finally, New York State Teachers Retirement System raised its holdings in shares of Hims & Hers Health by 95.2% during the first quarter. New York State Teachers Retirement System now owns 194,795 shares of the company's stock worth $5,756,000 after acquiring an additional 94,983 shares during the period. Institutional investors and hedge funds own 63.52% of the company's stock.

Hims & Hers Health Trading Down 3.2%

NYSE HIMS opened at $55.87 on Wednesday. Hims & Hers Health, Inc. has a 12 month low of $16.05 and a 12 month high of $72.98. The company has a current ratio of 4.98, a quick ratio of 4.46 and a debt-to-equity ratio of 1.72. The stock has a 50 day moving average of $50.94 and a 200-day moving average of $45.99. The company has a market cap of $12.63 billion, a PE ratio of 69.84, a PEG ratio of 3.90 and a beta of 2.14.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $544.83 million for the quarter, compared to the consensus estimate of $550.06 million. Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%.During the same period last year, the company posted $0.06 earnings per share. The business's revenue was up 72.6% compared to the same quarter last year. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts anticipate that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Insiders Place Their Bets

In other Hims & Hers Health news, CEO Andrew Dudum sold 660,000 shares of the business's stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $50.58, for a total transaction of $33,382,800.00. Following the transaction, the chief executive officer owned 2,214,769 shares of the company's stock, valued at $112,023,016.02. The trade was a 22.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Oluyemi Okupe sold 145,000 shares of the firm's stock in a transaction that occurred on Monday, September 15th. The shares were sold at an average price of $55.35, for a total value of $8,025,750.00. Following the completion of the sale, the chief financial officer directly owned 128,984 shares of the company's stock, valued at approximately $7,139,264.40. The trade was a 52.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,511,978 shares of company stock worth $76,944,116. Company insiders own 17.71% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on HIMS shares. UBS Group set a $30.00 target price on shares of Hims & Hers Health in a research note on Monday, June 23rd. Wall Street Zen cut Hims & Hers Health from a "buy" rating to a "hold" rating in a research report on Monday, July 28th. Truist Financial dropped their target price on Hims & Hers Health from $48.00 to $37.00 and set a "hold" rating on the stock in a research report on Monday, August 18th. Needham & Company LLC reaffirmed a "hold" rating on shares of Hims & Hers Health in a research report on Tuesday, August 5th. Finally, Morgan Stanley reaffirmed an "equal weight" rating and set a $40.00 price target on shares of Hims & Hers Health in a research note on Wednesday, June 11th. Two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, Hims & Hers Health currently has an average rating of "Reduce" and an average target price of $38.92.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.